1. Home
  2. AUUD vs BOLT Comparison

AUUD vs BOLT Comparison

Compare AUUD & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Auddia Inc.

AUUD

Auddia Inc.

HOLD

Current Price

$1.10

Market Cap

7.1M

Sector

Technology

ML Signal

HOLD

Logo Bolt Biotherapeutics Inc.

BOLT

Bolt Biotherapeutics Inc.

HOLD

Current Price

$3.87

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUUD
BOLT
Founded
2012
2015
Country
United States
United States
Employees
5
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
7.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AUUD
BOLT
Price
$1.10
$3.87
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$34.00
AVG Volume (30 Days)
225.8K
16.4K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,695,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$133.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.07
52 Week Low
$0.51
$3.75
52 Week High
$10.10
$7.20

Technical Indicators

Market Signals
Indicator
AUUD
BOLT
Relative Strength Index (RSI) 36.85 41.28
Support Level $0.86 N/A
Resistance Level $1.23 $5.05
Average True Range (ATR) 0.09 0.25
MACD -0.02 0.00
Stochastic Oscillator 11.88 6.94

Price Performance

Historical Comparison
AUUD
BOLT

About AUUD Auddia Inc.

Auddia Inc is a United States-based company. It operates through its proprietary AI platform for audio and is reinventing not only how consumers engage with AM/FM radio, podcasts, and other audio content but also how artists and labels promote their music and gain access to mainstream radio audiences. The group Discovr Radio is the first music-promotion platform to deliver artists guaranteed exposure to radio listeners. Its flagship audio superapp, called faidr, delivers multiple industry firsts, including: Ad-free listening on any AM/FM radio station, Content skipping across any AM/FM station, One-touch skipping of entire podcast ad breaks, and Integrated artist discovery experiences.

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

Share on Social Networks: